Abstract
Prolyl oligopeptidase (POP), is an 80-kDa serine protease that hydrolyzes peptides smaller than 30-mer at the carboxyl side of an internal proline-residue. POP is commonly believed to cleave a number of neuropeptides claimed to be involved in learning, memory and mood. While the support to the neuropeptide cleavage theory has been declining, new data suggest novel functions for POP, e.g. as a regulator of protein secretion, α-synuclein aggregation and cell proliferation/differentiation. Intriguingly, many of these novel functions may not depend on the hydrolytic activity of POP. One of the new roles is an involvement of POP in neurotransmission. Indeed, POP has been associated with a variety of different neurotransmitters. According to our previous results, POP is located in GABAergic and cholinergic neurotransmitter systems and in short glutamatergic projection neurons between cortex and thalamus. Based on these findings, POP may be involved in inhibitory and excitatory signal transmission and in the thalamocortical and corticothalamic signalling in the brain. It has also been shown that POP inhibition can affect the functions of neurotransmitters and that the ligands of neurotransmitter receptors can alter the activity of POP. Thus, there is a connection between the neurotransmitters and POP, although the mechanisms and the functional significance of this linkage are still unknown. Here, we will review the data about the connections of POP with conventional neurotransmitter systems and provide an overview of the role of POP in neurotransmission.
Keywords: Brain lesions, immunohistochemistry, neurotransmitters, prolyl oligopeptidase, POP, PEP, rat, stereotaxis, Sarcophaga peregrina, Thyrotropin-releasing hormone, Glutamate, GABA, Serotonin
CNS & Neurological Disorders - Drug Targets
Title: Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain
Volume: 10 Issue: 3
Author(s): Iida Peltonen, Timo T. Myohanen and Pekka T. Mannisto
Affiliation:
Keywords: Brain lesions, immunohistochemistry, neurotransmitters, prolyl oligopeptidase, POP, PEP, rat, stereotaxis, Sarcophaga peregrina, Thyrotropin-releasing hormone, Glutamate, GABA, Serotonin
Abstract: Prolyl oligopeptidase (POP), is an 80-kDa serine protease that hydrolyzes peptides smaller than 30-mer at the carboxyl side of an internal proline-residue. POP is commonly believed to cleave a number of neuropeptides claimed to be involved in learning, memory and mood. While the support to the neuropeptide cleavage theory has been declining, new data suggest novel functions for POP, e.g. as a regulator of protein secretion, α-synuclein aggregation and cell proliferation/differentiation. Intriguingly, many of these novel functions may not depend on the hydrolytic activity of POP. One of the new roles is an involvement of POP in neurotransmission. Indeed, POP has been associated with a variety of different neurotransmitters. According to our previous results, POP is located in GABAergic and cholinergic neurotransmitter systems and in short glutamatergic projection neurons between cortex and thalamus. Based on these findings, POP may be involved in inhibitory and excitatory signal transmission and in the thalamocortical and corticothalamic signalling in the brain. It has also been shown that POP inhibition can affect the functions of neurotransmitters and that the ligands of neurotransmitter receptors can alter the activity of POP. Thus, there is a connection between the neurotransmitters and POP, although the mechanisms and the functional significance of this linkage are still unknown. Here, we will review the data about the connections of POP with conventional neurotransmitter systems and provide an overview of the role of POP in neurotransmission.
Export Options
About this article
Cite this article as:
Peltonen Iida, T. Myohanen Timo and T. Mannisto Pekka, Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain, CNS & Neurological Disorders - Drug Targets 2011; 10 (3) . https://dx.doi.org/10.2174/187152711794653887
DOI https://dx.doi.org/10.2174/187152711794653887 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Study of Oxidized Lipids as Endogenous Substrates of P-gp (ABCB1)
Drug Metabolism Letters Biochemical Changes Evidenced in Alzheimer's Disease: A Mini-Review
Letters in Drug Design & Discovery Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Nitric Oxide-Derived Oxidants with a Focus on Peroxynitrite: Molecular Targets,Cellular Responses and Therapeutic Implications
Current Pharmaceutical Design Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology Directed Functional Connectivity of Posterior Cingulate Cortex and Whole Brain in Alzheimer's Disease and Mild Cognitive Impairment
Current Alzheimer Research Soy Isoflavone Alleviates Aβ1-42-Induced Impairment of Learning and Memory Ability Through the Regulation of RAGE/LRP-1 in Neuronal and Vascular Tissue
Current Neurovascular Research Tau in Alzheimer Disease and Related Tauopathies
Current Alzheimer Research Assessing Medication Problems in those ≥ 65 Using the STOPP and START Criteria
Current Aging Science Advanced Therapies For End-Stage Heart Failure
Current Cardiology Reviews Altered Functional Connectivity of the Marginal Division in Alzheimer’s Disease
Current Alzheimer Research Ceruloplasmin, the Unique Multi-Copper Oxidase of Vertebrates
Protein & Peptide Letters Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Perioperative Heart-Brain Axis Protection in Obese Surgical Patients: The Nutrigenomic Approach
Current Medicinal Chemistry Environmental Enrichment Influences BDNF and NR1 Levels in the Hippocampus and Restores Cognitive Impairment in Chronic Cerebral Hypoperfused Rats
Current Neurovascular Research Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nonconvulsive (Dialeptic) Status Epilepticus in Children
Current Pediatric Reviews Valosin Containing Protein Associated Fronto-Temporal Lobar Degeneration:Clinical Presentation, Pathologic Features and Pathogenesis
Current Alzheimer Research Obesity and Cardiovascular Physiology: Impact of some Pharmacological Agents
Current Vascular Pharmacology Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets